Bernhardt G. Zeiher - 04 Apr 2023 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
04 Apr 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 17:17:15 UTC
Next filing
15 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Award $0 +32,000 $0.000000 32,000 04 Apr 2023 Common Stock 32,000 $14.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in equal monthly installments over three years from the date of grant, subject to the reporting person's continuous service through the applicable vesting date.